<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36475766</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Enterovirus-Cardiomyocyte Interactions: Impact of Terminally Deleted Genomic RNAs on Viral and Host Functions.</ArticleTitle><Pagination><StartPage>e0142622</StartPage><MedlinePgn>e0142622</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01426-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.01426-22</ELocationID><Abstract><AbstractText>Group B enteroviruses, including coxsackievirus B3 (CVB3), can persistently infect cardiac tissue and cause dilated cardiomyopathy. Persistence is linked to 5' terminal deletions of viral genomic RNAs that have been detected together with minor populations of full-length genomes in human infections. In this study, we explored the functions and interactions of the different viral RNA forms found in persistently infected patients and their putative role(s) in pathogenesis. Since enterovirus cardiac pathogenesis is linked to the viral proteinase 2A, we investigated the effect of different terminal genomic RNA deletions on 2A activity. We discovered that 5' terminal deletions in CVB3 genomic RNAs decreased the levels of 2A proteinase activity but could not abrogate it. Using newly generated viral reporters encoding nano-luciferase, we found that 5' terminal deletions resulted in decreased levels of viral protein and RNA synthesis in singly transfected cardiomyocyte cultures. Unexpectedly, when full-length and terminally deleted forms were cotransfected into cardiomyocytes, a cooperative interaction was observed, leading to increased viral RNA and protein production. However, when viral infections were carried out in cells harboring 5' terminally deleted CVB3 RNAs, a decrease in infectious particle production was observed. Our results provide a possible explanation for the necessity of full-length viral genomes during persistent infection, as they would stimulate efficient viral replication compared to that of the deleted genomes alone. To avoid high levels of viral particle production that would trigger cellular immune activation and host cell death, the terminally deleted RNA forms act to limit the production of viral particles, possibly as <i>trans</i>-dominant inhibitors. <b>IMPORTANCE</b> Enteroviruses like coxsackievirus B3 are able to initiate acute infections of cardiac tissue and, in some cases, to establish a long-term persistent infection that can lead to serious disease sequelae, including dilated cardiomyopathy. Previous studies have demonstrated the presence of 5' terminally deleted forms of enterovirus RNAs in heart tissues derived from patients with dilated cardiomyopathy. These deleted RNAs are found in association with very low levels of full-length enterovirus genomic RNAs, an interaction that may facilitate continued persistence while limiting virus particle production. Even in the absence of detectable infectious virus particle production, these deleted viral RNA forms express viral proteinases at levels capable of causing viral pathology. Our studies provide mechanistic insights into how full-length and deleted forms of enterovirus RNA cooperate to stimulate viral protein and RNA synthesis without stimulating infectious viral particle production. They also highlight the importance of targeting enteroviral proteinases to inhibit viral replication while at the same time limiting the long-term pathologies they trigger.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bouin</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Molecular Genetics, School of Medicine and Center for Virus Research, University of California, Irvine, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu</LastName><ForeName>Michelle N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Molecular Genetics, School of Medicine and Center for Virus Research, University of California, Irvine, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Hakeem</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Molecular Genetics, School of Medicine and Center for Virus Research, University of California, Irvine, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Genevieve P</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Molecular Genetics, School of Medicine and Center for Virus Research, University of California, Irvine, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Joseph H C</ForeName><Initials>JHC</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Molecular Genetics, School of Medicine and Center for Virus Research, University of California, Irvine, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semler</LastName><ForeName>Bert L</ForeName><Initials>BL</Initials><Identifier Source="ORCID">0000-0002-2424-5155</Identifier><AffiliationInfo><Affiliation>Department of Microbiology &amp; Molecular Genetics, School of Medicine and Center for Virus Research, University of California, Irvine, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI155962</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI145003</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002311" MajorTopicYN="Y">Cardiomyopathy, Dilated</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088562" MajorTopicYN="N">Persistent Infection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA replication</Keyword><Keyword MajorTopicYN="N">cardiomyocytes</Keyword><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword><Keyword MajorTopicYN="N">persistence</Keyword><Keyword MajorTopicYN="N">picornavirus</Keyword><Keyword MajorTopicYN="N">proteinase</Keyword><Keyword MajorTopicYN="N">translation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>8</Day><Hour>9</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36475766</ArticleId><ArticleId IdType="pmc">PMC9888282</ArticleId><ArticleId IdType="doi">10.1128/jvi.01426-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tapparel C, Siegrist F, Petty TJ, Kaiser L. 2013. Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol 14:282&#x2013;293. 10.1016/j.meegid.2012.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2012.10.016</ArticleId><ArticleId IdType="pubmed">23201849</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R, Delwart E, Gorbalenya AE, Hovi T, King AMQ, Knowles NJ, Lindberg AM, Pallansch MA, Palmenberg AC, Reuter G, Simmonds P, Skern T, Stanway G, Yamashita T, Ictv Report C. 2017. ICTV virus taxonomy profile: Picornaviridae. J Gen Virol 98:2421&#x2013;2422. 10.1099/jgv.0.000911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000911</ArticleId><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;usslich H-G, Nicklin MJH, Lee C-K, Wimmer E. 1988. Polyprotein processing in picornavirus replication. Biochimie 70:119&#x2013;130. 10.1016/0300-9084(88)90166-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0300-9084(88)90166-6</ArticleId><ArticleId IdType="pubmed">2840974</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura N, Semler BL, Rothberg PG, Larsen GR, Adler CJ, Dorner AJ, Emini EA, Hanecak R, Lee JJ, van der Werf S, Anderson CW, Wimmer E. 1981. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 291:547&#x2013;553. 10.1038/291547a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/291547a0</ArticleId><ArticleId IdType="pubmed">6264310</ArticleId></ArticleIdList></Reference><Reference><Citation>Leveque N, Semler BL. 2015. A 21st century perspective of poliovirus replication. PLoS Pathog 11:e1004825. 10.1371/journal.ppat.1004825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004825</ArticleId><ArticleId IdType="pmc">PMC4456262</ArticleId><ArticleId IdType="pubmed">26042673</ArticleId></ArticleIdList></Reference><Reference><Citation>Golpour A, Patriki D, Hanson PJ, McManus B, Heidecker B. 2021. Epidemiological Impact of Myocarditis. J Clin Med 10. 10.3390/jcm10040603.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10040603</ArticleId><ArticleId IdType="pmc">PMC7915005</ArticleId><ArticleId IdType="pubmed">33562759</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack A, Kontorovich AR, Fuster V, Dec GW. 2015. Viral myocarditis&#x2013;diagnosis, treatment options, and current controversies. Nat Rev Cardiol 12:670&#x2013;680. 10.1038/nrcardio.2015.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2015.108</ArticleId><ArticleId IdType="pubmed">26194549</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennert R, Crijns HJ, Heymans S. 2008. Acute viral myocarditis. Eur Heart J 29:2073&#x2013;2082. 10.1093/eurheartj/ehn296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehn296</ArticleId><ArticleId IdType="pmc">PMC2519249</ArticleId><ArticleId IdType="pubmed">18617482</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A, Gretteau PA, Wehbe M, Renois F, N'Guyen Y, Leveque N, Vu MN, Tracy S, Chapman NM, Bruneval P, Fornes P, Semler BL, Andreoletti L. 2019. Enterovirus persistence in cardiac cells of patients with idiopathic dilated cardiomyopathy is linked to 5' terminal genomic RNA-deleted viral populations with viral-encoded proteinase activities. Circulation 139:2326&#x2013;2338. 10.1161/CIRCULATIONAHA.118.035966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.035966</ArticleId><ArticleId IdType="pmc">PMC6517084</ArticleId><ArticleId IdType="pubmed">30755025</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Bourlet T, Andreoletti L, Mosnier JF, Peng T, Yang Y, Archard LC, Pozzetto B, Zhang H. 2000. Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy. Circulation 101:231&#x2013;234. 10.1161/01.cir.101.3.231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.101.3.231</ArticleId><ArticleId IdType="pubmed">10645916</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen Y, Renois F, Leveque N, Giusti D, Picard-Maureau M, Bruneval P, Fornes P, Andreoletti L. 2013. Virus detection and semiquantitation in explanted heart tissues of idiopathic dilated cardiomyopathy adult patients by use of PCR coupled with mass spectrometry analysis. J Clin Microbiol 51:2288&#x2013;2294. 10.1128/JCM.00820-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00820-13</ArticleId><ArticleId IdType="pmc">PMC3697695</ArticleId><ArticleId IdType="pubmed">23658274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KS, Tracy S, Tapprich W, Bailey J, Lee CK, Kim K, Barry WH, Chapman NM. 2005. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol 79:7024&#x2013;7041. 10.1128/JVI.79.11.7024-7041.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.11.7024-7041.2005</ArticleId><ArticleId IdType="pmc">PMC1112132</ArticleId><ArticleId IdType="pubmed">15890942</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman NM, Kim KS, Drescher KM, Oka K, Tracy S. 2008. 5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart. Virology 375:480&#x2013;491. 10.1016/j.virol.2008.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.02.030</ArticleId><ArticleId IdType="pmc">PMC2440640</ArticleId><ArticleId IdType="pubmed">18378272</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman NM. 2022. Persistent enterovirus infection: little deletions, long infections. Vaccines (Basel) 10:770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9143164</ArticleId><ArticleId IdType="pubmed">35632526</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaramillo L, Smithee S, Tracy S, Chapman NM. 2016. Domain I of the 5' non-translated genomic region in coxsackievirus B3 RNA is not required for productive replication. Virology 496:127&#x2013;130. 10.1016/j.virol.2016.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.05.021</ArticleId><ArticleId IdType="pubmed">27289561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim KS, Chapman NM, Tracy S. 2008. Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions. J Virol 82:2033&#x2013;2037. 10.1128/JVI.01774-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01774-07</ArticleId><ArticleId IdType="pmc">PMC2258713</ArticleId><ArticleId IdType="pubmed">18057248</ArticleId></ArticleIdList></Reference><Reference><Citation>Flather D, Semler BL. 2015. Picornaviruses and nuclear functions: targeting a cellular compartment distinct from the replication site of a positive-strand RNA virus. Front Microbiol 6:594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4471892</ArticleId><ArticleId IdType="pubmed">26150805</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciejewski S, Semler BL. 2018. Hijacking host functions for translation and RNA replication by enteroviruses, p 23&#x2013;50. In Jackson WT, Coyne CB (ed), Enteroviruses: omics, Molecular Biology, and Control. Caister Academic Press, United Kingdom.</Citation></Reference><Reference><Citation>Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU. 1999. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320&#x2013;326. 10.1038/6543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/6543</ArticleId><ArticleId IdType="pubmed">10086389</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong D, Yajima T, Lim BK, Stenbit A, Dublin A, Dalton ND, Summers-Torres D, Molkentin JD, Duplain H, Wessely R, Chen J, Knowlton KU. 2007. Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy. Circulation 115:94&#x2013;102. 10.1161/CIRCULATIONAHA.106.631093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.631093</ArticleId><ArticleId IdType="pubmed">17190866</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnabei MS, Sjaastad FV, Townsend D, Bedada FB, Metzger JM. 2015. Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment. Sci Transl Med 7:294ra106.</Citation><ArticleIdList><ArticleId IdType="pubmed">26136477</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsley TB, Towner JS, Blyn LB, Ehrenfeld E, Semler BL. 1997. Poly (rC) binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA 3:1124&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369554</ArticleId><ArticleId IdType="pubmed">9326487</ArticleId></ArticleIdList></Reference><Reference><Citation>Andino R, Rieckhof GE, Baltimore D. 1990. A functional ribonucleoprotein complex forms around the 5' end of poliovirus RNA. Cell 63:369&#x2013;380. 10.1016/0092-8674(90)90170-J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(90)90170-J</ArticleId><ArticleId IdType="pubmed">2170027</ArticleId></ArticleIdList></Reference><Reference><Citation>Yajima T, Knowlton KU. 2009. Viral myocarditis: from the perspective of the virus. Circulation 119:2615&#x2013;2624. 10.1161/CIRCULATIONAHA.108.766022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.766022</ArticleId><ArticleId IdType="pubmed">19451363</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R. 1992. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 89:314&#x2013;318. 10.1073/pnas.89.1.314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.89.1.314</ArticleId><ArticleId IdType="pmc">PMC48227</ArticleId><ArticleId IdType="pubmed">1309611</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Lederer WJ, Kandolf R, Knowlton KU. 1998. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest 102:1444&#x2013;1453. 10.1172/JCI1972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI1972</ArticleId><ArticleId IdType="pmc">PMC508992</ArticleId><ArticleId IdType="pubmed">9769337</ArticleId></ArticleIdList></Reference><Reference><Citation>Leveque N, Garcia M, Bouin A, Nguyen JHC, Tran GP, Andreoletti L, Semler BL. 2017. Functional consequences of RNA 5'-terminal deletions on coxsackievirus B3 RNA replication and ribonucleoprotein complex formation. J Virol 91:e00423-17. 10.1128/JVI.00423-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00423-17</ArticleId><ArticleId IdType="pmc">PMC5533909</ArticleId><ArticleId IdType="pubmed">28539455</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenet M, N'Guyen Y, Mirand A, Henquell C, Lebreil AL, Berri F, Bani-Sadr F, Lina B, Schuffenecker I, Andreoletti L, French Enterovirus Myocarditis Study G, French Enterovirus Myocarditis Study Group (FEMSG) . 2020. Major 5'terminally deleted enterovirus populations modulate type I IFN response in acute myocarditis patients and in human cultured cardiomyocytes. Sci Rep 10:11947. 10.1038/s41598-020-67648-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67648-5</ArticleId><ArticleId IdType="pmc">PMC7371739</ArticleId><ArticleId IdType="pubmed">32686697</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray KE, Roberts AW, Barton DJ. 2001. Poly(rC) binding proteins mediate poliovirus mRNA stability. RNA 7:1126&#x2013;1141. 10.1017/s1355838201010044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1355838201010044</ArticleId><ArticleId IdType="pmc">PMC1370160</ArticleId><ArticleId IdType="pubmed">11497431</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempf BJ, Barton DJ. 2008. Poly(rC) binding proteins and the 5' cloverleaf of uncapped poliovirus mRNA function during de novo assembly of polysomes. J Virol 82:5835&#x2013;5846. 10.1128/JVI.01513-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01513-07</ArticleId><ArticleId IdType="pmc">PMC2395131</ArticleId><ArticleId IdType="pubmed">18400854</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouin A, Semler BL. 2020. Picornavirus cellular remodeling: doubling down in response to viral-induced inflammation. Curr Clin Microbiol Rep 7:31&#x2013;37. 10.1007/s40588-020-00138-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40588-020-00138-4</ArticleId><ArticleId IdType="pmc">PMC7377643</ArticleId><ArticleId IdType="pubmed">32704466</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrault J. 1981. Origin and replication of defective interfering particles. Curr Top Microbiol Immunol 93:151&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">7026180</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux L, Simon AE, Holland JJ. 1991. Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo. Adv Virus Res 40:181&#x2013;211. 10.1016/S0065-3527(08)60279-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(08)60279-1</ArticleId><ArticleId IdType="pmc">PMC7131706</ArticleId><ArticleId IdType="pubmed">1957718</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs NT, Onuoha NO, Antia A, Steel J, Antia R, Lowen AC. 2019. Incomplete influenza A virus genomes occur frequently but are readily complemented during localized viral spread. Nat Commun 10:3526. 10.1038/s41467-019-11428-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11428-x</ArticleId><ArticleId IdType="pmc">PMC6684657</ArticleId><ArticleId IdType="pubmed">31387995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhl U, Lassner D, von Schlippenbach J, Poller W, Schultheiss HP. 2012. Interferon-Beta improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol 60:1295&#x2013;1296. 10.1016/j.jacc.2012.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2012.06.026</ArticleId><ArticleId IdType="pubmed">23017536</ArticleId></ArticleIdList></Reference><Reference><Citation>Cathcart AL, Rozovics JM, Semler BL. 2013. Cellular mRNA decay protein AUF1 negatively regulates enterovirus and human rhinovirus infections. J Virol 87:10423&#x2013;10434. 10.1128/JVI.01049-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01049-13</ArticleId><ArticleId IdType="pmc">PMC3807403</ArticleId><ArticleId IdType="pubmed">23903828</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>